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336 The Journal of Thoracic and CardioObjective: We have used artificial chordal replacement with expanded polytetra-
fluoroethylene sutures for mitral valve repair in children and reported favorable
early clinical results. In this article we evaluate the midterm results of mitral valve
repair with expanded polytetrafluoroethylene sutures in 39 children.
Methods: From April 1995 through September 2003, mitral valve repair with
chordal replacement using expanded polytetrafluoroethylene sutures was performed
in 39 patients. In all patients the preoperative grade of mitral regurgitation was
moderate or more because of prolapse of the anterior mitral leaflet. The mean age
and body weight at the time of the operation were 4.7  5.3 years (range, 1 month
to 17.8 years) and 14.4  12.2 kg (range, 3.9-54.4 kg), respectively. The number of
expanded polytetrafluoroethylene sutures ranged from 1 to 3 (mean, 1.4). The mean
follow-up period and body weight at the latest follow-up were 5.0  2.3 years
(range, 1.1-8.5 years) and 25.7  16.4 kg (range, 6.9-73 kg), respectively.
Results: There were no operative or late deaths. Only one patient required mitral
valve replacement, which occurred 17 days after repair. Two patients underwent
redo mitral valve repair 2 and 5 years after initial repair, respectively. The actuarial
freedom from reoperation at 5 and 8 years was 94.8% and 89.5%, respectively. At
the latest follow-up, trivial or less mitral regurgitation was observed in 33 (84.6%)
patients.
Conclusions: Mitral valve repair with expanded polytetrafluoroethylene sutures in
children demonstrated favorable midterm outcome. The procedure is safe and
effective, with potential for patients’ growth.
For mitral valve (MV) reconstruction, various techniques have beenused to avoid prosthetic valve replacement, especially in children.Recently, MV plasty in children has gained popularity, and its oper-ative results are satisfactory.1-3 However, mitral regurgitation (MR)caused by anterior leaflet prolapse is sometimes more difficult torepair with a simple method, such as triangular resection, chordal
shortening, or chordal transfer.4,5
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DChordal replacement with expanded polytetrafluoroeth-
ylene (ePTFE) sutures was introduced as an alternate tech-
nique for MV repair, and favorable early outcomes have
been reported, including our previous study.1,6 Recently,
this procedure has become an essential component in the
armamentarium for MV plasty in children. However, the
long-term durability and biologic adaptation of ePTFE su-
tures after patient growth has been a great concern. There-
fore, in this study we evaluated the midterm effectiveness of
chordal replacement with ePTFE sutures for MV repair in
39 children operated on during the past 8 years.
Patients and Methods
Patients
From April 1995 through December 2003, we performed MV
repair with chordal replacement using ePTFE in 39 children. The
patient group consisted of 9 male and 30 female subjects with a
mean age of 4.7  5.3 years (range, 1 month to 17.8 years) and
body weight at the time of the operation of 14.4  12.2 kg (range,
3.9-54.4 kg). A total of 11 (28.2%) of 39 patients underwent MV
repair before 1 year of age. The grade of MR at the operation was
moderate in 34 (89%) patients and severe in 5 (13%) patients. All
patients had anterior mitral leaflet prolapse (39/39 [100%]) that
was caused by chordal elongation in 20 (51%) patients, torn
chordae in 14 (36%) patients, and absent chordae in 5 (13%)
patients. Associated cardiac anomalies were present in 23 (59%)
patients, as shown in Table 1. Nine patients had a history of
previous cardiac operations, including MV plasty in 3 patients,
closure of ventricular septal defect in 2 patients, closure of atrial
septal defect in 1 patient, bidirectional Glenn procedure in 1
patient, ligation of patent ductus arteriosus in 1 patient, and central
shunt in 1 patient. Informed consent was obtained from patients
before surgical intervention, and this study was approved by our
institutional review board.
Indications for MV Repair
The indication for surgical intervention was based on the experi-
ence of our institution. Medical therapy, including angiotensin-
converting enzyme inhibitors and diuretics, were initiated by re-
ferring pediatric cardiologists. Before surgical consultation, most
of the patients experienced severe MR. Moderate or severe MR,
despite optimal medical treatment, with an episode of congestive
heart failure and significant morphologic changes of the anterior
leaflet prolapse is our indication for surgical intervention. Pulmo-
nary hypertension (mean pulmonary artery pressure  20 mm Hg
by means of a Swan-Ganz catheter) was observed in 25 (64%)
patients. Preoperative ventilator support was necessary in 6 (15%)
patients.
Surgical Procedures
Our original procedure was described previously, as shown in
Figure 1.1 In brief, during cardiopulmonary bypass the MV was
approached through a left atriotomy (34 patients) or atrial
septostomy (5 patients). We placed double-armed mattress su-
tures of 4-0, 5-0, or 6-0 ePTFE reinforced with felt pledgets
between the papillary muscle and free margin of the anterior
leaflet. The length of the ePTFE sutures was adjusted with the
The Journal of Thoraciadjacent normal anterior leaflet or facing posterior leaflet. When
the prolapsed portion was wide, another ePTFE suture was
placed in the same fashion. The number of ePTFE sutures
ranged from 1 to 3 (mean, 1.4; 1 suture in 25 [64%] patients, 2
sutures in 12 [31%] patients, and 3 sutures in 2 [5%] patients).
In addition, Kay-Reed annuloplasty was performed in all pa-
tients to correct annular dilatation. In 18 patients concomitant
repair of a congenital cardiac anomaly was performed. After
completion of MV repair to examine the competency of the
MV, the left ventricle was filled with fluid injected across the
MV into the left ventricle. Valvular function and anatomy were
further assessed with transesophageal or epicardial echocardi-
ography while the patient was weaned from cardiopulmonary
bypass. All patients received warfarin anticoagulation for 3
months postoperatively.
Follow-up
Follow-up was completed in all patients, with a mean period of 5.0
 2.3 years (range, 1.1-8.5 years). The mean body weight at the
latest evaluation was 25.7  16.4 kg (range, 6.9-73.0 kg). During
the follow-up period, all patients were evaluated annually by
transthoracic echocardiography at our hospital. If multiple echo-
cardiographic measurements were obtained, the latest one was
taken into the analysis. The normal size of the mitral annular
diameter and the left ventricular diastolic dimension were calcu-
lated from body surface area, according to the method of Kirklin
and Barratt-Boyes.7
Functional Assessment of the MV
To assess the adaptability of ePTFE sutures in accordance to the
patients’ growth, we measured (1) the distance between the
plane of the mitral annulus and the top of the papillary muscle
(AP distance) and (2) the diameter of the mitral annulus (MV
diameter) at the end-systolic phase, as shown in Figure 2. The
AP distance reflected the depth of the mitral coaptation zone
and the length of the artificial chordae. The ratio of MV
diameter to AP distance was calculated and was compared with
that of 50 control children with normal hearts (age, 4.2  3.1
years [range, 2 months to 10.8 years]; body weight, 15.7  10.1
TABLE 1. Associated cardiac anomalies
N (%)
No cardiac anomalies 16 41
Ventricular septal defect 9 23
Atrial septal defect 4 10
Bland-White-Garland syndrome 2 5
Left coronary artery obstruction 2 5
Pulmonary atresia/intact ventricular septum 1 3
Complete form of atrioventricular septal defect 1 3
Tricuspid atresia 1 3
Double-chambered right ventricle 1 3
Patent ductus arteriosus 1 3
Double aortic arch 1 3kg [range, 1.9-44.3 kg]).
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DData Analysis
The continuous data in this study are expressed as mean values 
SD. Paired t tests were performed to analyze the differences
between variables. Freedom from reoperation was calculated by
the Kaplan-Meier method and expressed as mean values  SE.
Statistical analysis was performed with StatView (SAS Institute,
Cary, NC).
Results
Surgical Results
There were no hospital deaths. The preoperative and post-
Figure 1. Surgical method of MV repair. A, A double-a
the prolapsed leaflet and through the papillary muscle
through a pledget on the side of the muscle, where the
was drawn until the leaflet was drawn to the papillary
level of the opposing normal leaflet. C, The new chorda
the pledget came up against the muscle.
Figure 2. Postoperative echocardiography in 4-chambe
the mitral annulus; AP distance, distance between theoperative grades of MR are shown in Figure 3. A 3-month-
338 The Journal of Thoracic and Cardiovascular Surgery ● Febrold boy had residual MR with symptoms of heart failure
during the hospital stay. His MR was trivial immediately
after the operation, but it became more significant over 15
days after the operation, requiring endotracheal intubation
and inotropic support to control heart failure. The patient
was taken back to the operating room for redo MV surgery.
Transthoracic echocardiography after achievement of gen-
eral anesthesia demonstrated moderate MR, and rupture of
the chordae was suspected. At the time of the operation, all
ePTFE artificial chordae were intact; however, friable leaf-
lets and multiple de novo chordal ruptures were encoun-
ePTFE suture was passed through the rough zone of
to 4 mm from its top. The sutures were then passed
res emerged from the papillary muscle. B, This suture
cle. The knot was then tied a little longer than at the
re then pulled back through the papillary muscle until
w at the end-systolic phase. MV diameter, Diameter of
al annulus and the top of the papillary muscle.rmed
at 3
sutu
mus
e wer vietered. The MV could not be repaired, and therefore MV
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Dreplacement was performed with a 16-mm mechanical pros-
thesis.
Clinical Follow-up Results
During follow-up, the degree of MR was recorded as shown
in Figure 3. A total of 36 patients had mild or less MR at the
latest follow-up echocardiography. Two patients with mod-
erate MR underwent repeat MV plasty. A 5-month-old boy
who had anterior leaflet prolapse underwent repeat MV
plasty with ePTFE sutures 2 years after the initial operation.
A 6-year-old girl who had a recurrence of MR related to a
partial atrioventricular septal defect underwent closure of
the MV cleft 5 years after the initial operation. These 2
patients who required reoperation are currently doing well
without significant MR. Among the patients who had pre-
operatively severe MR (5 patients), 4 patients did not have
any MR during follow-up. However, 1 patient (the previ-
ously mentioned 5-month-old boy) required redo MV
plasty. There have been no late deaths. The actuarial free-
dom from reoperation was 94.8%  0.4% at 5 years and
89.5%  0.6% at 8 years, as shown in Figure 4. During the
follow-up period, there was no thromboembolism.
Echocardiographic Follow-up Results
Mitral annular diameter, left ventricular diastolic diameter,
and mitral flow velocity normalized in all patients on the
basis of echocardiography during the follow-up period, as
shown in Table 2. Although thickening of ePTFE was
observed with time, restrictive movement of the mitral
leaflet was not found in any patients.
The ratios of MV diameter to AP distance at early and
late follow-up in 39 patients and the control group are
Figure 3. Comparison of preoperative and postoperative MR. One
patient underwent MV replacement after the operation, and 2
additional patients underwent redo MV repair in a late follow-up
period.shown in Figure 5. These measurements in 16 patients
The Journal of Thoraciwhose body surface area increased more than 1.5 times are
shown in Figure 6. The ratio of MV diameter to AP distance
at early and late follow-up with a mean interval of 5.0 years
was unchanged in 39 patients and similar to that seen in
healthy subjects.
Operations for Patients Less Than 1 Year of Age
Eleven patients were younger than 1 year of age. In this
younger group the mean age and body weight at the time of
the operation were 6.9 months (range, 3.5-11.9 months) and
5.5 kg (range, 3.9-8.3 kg). The mean follow-up period and
body weight at the longest follow-up were 3.4 years (range,
1.2-6.2 years) and 12.2 kg (range, 6.9-17.0 kg). The grade of
MR at the latest follow-up was less than trivial in 6 (55%)
Figure 4. Actuarial freedom from reoperation after MV repair
with ePTFE sutures.
Figure 5. Ratio of the diameter of the mitral annulus to the
distance between the plane of the mitral annulus and the top of
the papillary muscle, as measured by means of echocardiography
(MV diameter/AP distance).patients and mild in 3 (27%) patients. Moderate or more MR
c and Cardiovascular Surgery ● Volume 129, Number 2 339
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formed as described above.
Discussion
Since David and colleagues8 first described an MV repair
method with artificial chordae for the treatment of anterior
leaflet prolapse, there have been numerous studies concern-
ing the effectiveness of this procedure. Eishi and col-
leagues9 reported actuarial freedom from reoperation for
this procedure of 96% at 8 years. However, this technique
remained an uncommon procedure in children, probably
because of concern for patient growth and a lack of long-
term follow-up.
We treated 22 patients with MR caused by anterior leaflet
prolapse before the introduction of the chordal replacement
technique in our institution. In these 22 patients, 4 mitral valve
replacements were performed as a result of failed MV plasty,
and the remaining 18 patients underwent MV plasty without
chordae repair. One operative death and 2 late deaths occurred.
Figure 6. Changes of the ratio of MV diameter to AP
patients whose body surface areas were increased m
plane of the mitral annulus and the top of the papillary
TABLE 2. Preoperative and postoperative echocardiograph
Before surgical
intervention
Annular diameter (mm) 23.6 6.8 (11.0-35.0)
% Normal 150 25
LVDd (mm) 41.9 11.2 (23.0-66.0)
% Normal 146 21
Flow velocity (cm/s)
Values are expressed as means  SD. LVDd, Left ventricular diastolic di
Predicted normal annular diameter (mm)  20.1  14.5  Log(BSA).
% Normal annular diameter (mm)  [Actuarial measurement of annular d
Predicted normal LVDd (mm)  38  32.1  Log(BSA).
*Denotes a statistically significant value when compared with preoperatiAt follow-up, trivial or less MR was observed in 10 (59%)
340 The Journal of Thoracic and Cardiovascular Surgery ● Febrpatients, mild MR in 2 (12%) patients, and moderate MR in 5
(29%) patients. Five of these patients with moderate MR
underwent reoperations: mitral valve replacement in 4 and MV
plasty in 1. The actuarial freedom from reoperation for MV
plasty without chordae repair was 85.9% at 5 years and 75.2%
at 10 years, with a mean follow-up period of 8.7  6.0 years.
These poor results from MV repair without chordae replace-
ment (conventional techniques, such as annuloplasty, leaflet
resection, and chordal shortening or translocation) were ac-
ceptable. However, management of the anterior leaflet pro-
lapse associated with torn or absent chordae by using conven-
tional techniques alone appeared to be suboptimal. Successful
reports of annuloplasty alone in children have been reported
previously.5 However, even in these reports, the late results of
MR caused by absent chordae were not always satisfactory,
and artificial chordal replacement for those patients was rec-
ommended. Chordal replacement is theoretically an ideal in-
dication for patients with torn or absent chordae. In our series
there were 19 patients with torn or absent chordae and 20 with
nce between postoperative and late follow-up in 16
han 1.5 times. AP distance, The distance between the
cle; MV diameter, the diameter of the mitral annulus.
tudies of mitral valve
Before discharge from
the hospital Late follow-up
16.0 3.1* (11.3-23.1) 20.1 4.5 (11.8-30.6)
103 27* 105 13
32.4 9.0* (16.0-56.0) 38.0 8.3 (26.0-58.0)
109 14* 108 14
103 18 115 25
r; BSA, body surface area.
er]/[Predicted normal annular diameter]  100
asurements (P  .05).dista
ore tic s
amete
iametelongated chordae, and reoperation was required in 10.5% and
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that chordal replacement can effectively control MR, regard-
less of the nature of the chordal pathology.
Our follow-up results of artificial chordal placement (re-
operation freedom of 94.7% at 5 years and 89.5% at 8 years)
appeared to be superior to those of previous studies of MV
repair without chordal replacement techniques (eg, 84%
freedom at 7 years, as shown by McCarthy and associates2),
although direct comparison is difficult. Our findings justify
the use of ePTFE artificial chordae in children to replace
elongated or ruptured chordae tendineae, to reinforce friable
chordae, or both, including for patients with severe MR.
These favorable clinical outcomes are supported by echo-
cardiographic follow-up results. Most patients (92%) remained
with mild or less MR. Annular distance and left ventricular
diastolic diameter were unchanged over the follow-up period.
The findings of MV diameter/AP distance ratio were interest-
ing, especially for patients with significant somatic growth
(Figure 6). The MV diameter/AP distance ratios became nor-
mal heart measurements at the time of the operation and
remained unchanged for years after the operation (Figure 5).
This suggests that once the relationship of the valve leaflets and
subvalvular apparatus is corrected by surgical intervention, it
will stay in normal proportions afterward. Because of the
nearly normal mitral annular diameter and the unchanged ratio
of MV diameter to AP distance in the follow-up period, the AP
distance must have increased over the years after surgical
intervention as the child grew. These observations might be
explained by a compensatory extensive growth of the mitral
leaflet and papillary muscle in the patients who underwent
chordal replacement with ePTFE, a type of biologic adaptation.
Three-dimensional echocardiographic analysis would be help-
ful to obtain more accurate geometry of the MV to confirm our
theory.10,11
MV plasty in the patients younger than 12 months can be
difficult because of the complex morphology, nature, and fri-
ability of mitral leaflets and the small operative field. Congen-
ital MR is often associated with subvalvular anomalies, such as
papillary muscle hypoplasia, which makes MV repair more
complex. Surgical exposure of the MV for these small children
can be accomplished with an extended left atriotomy with
transection of the superior or inferior vena cava. We believe
our midterm results of MV repair with artificial chordae for
these young patients are within the acceptable range: 8-year
survival of 100% and reoperation-free rate of 82%. A compa-
rable study of MV repair for patients aged 12 months or
younger was reported by Uva and coworkers,4 with a 7-year
survival of 94% and a reoperation-free rate of 58%.
In adults annuloplasty with a prosthetic ring is consid-
ered an essential part of the operation to prevent annular
dilatation. However, it would not be the procedure of choice
for children undergoing rapid somatic growth. The possible
problems related to implantation of a prosthetic ring are
The Journal of Thoraci3-dimensional annular motion mismatch, posterior leaflet
immobilization, and valve distortion.12 Thus, we applied
Kay-Reed annuloplasty as a part of MV leaflet repair.
This study was limited as a retrospective single-center
experience. Continued surveillance is necessary to confirm
long-term results.
In conclusion, the midterm outcomes for repair of ante-
rior prolapse of the MV with ePTFE chordae in children
were favorable. The echocardiographic study of MV appa-
ratus suggests that this procedure has potential benefits for
the patient who will undergo somatic growth.
We thank Dr Yoshie Ochiai, Dr O. P. Yadava, and Dr Tom R.
Karl for their editorial assistance in the preparation of this article.
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Discussion
Dr Joseph A. Dearani (Rochester, Minn). I congratulate and
commend Dr Minami and colleagues for this important contribu-
tion in the use of artificial chordae during MV repair in small
children. Your technique of artificial cord placement is elegant,
simple, and reproducible, and it adds to the surgeon’s armamen-
tarium of repair options when addressing mitral and, occasionally,
tricuspid regurgitation.
c and Cardiovascular Surgery ● Volume 129, Number 2 341
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to surgeons is that no apparent negative effect of placing artificial
chordae in a growing child was demonstrated in the early-to-
midterm follow-up of 5 to 8 years.
Thorough and careful echocardiographic examinations of the
MV anatomy were performed. The authors determined that the
ratio of MV diameter to the distance between the plane of the
mitral annulus and the top of the anterior papillary muscle did not
change when compared with that seen in control subjects, despite
the presence of considerable somatic growth. Their findings of
good valve function, preserved leaflet mobility, and the absence of
valve tethering in the vast majority of patients is reassurance to
clinicians that the use of artificial chordae does not appear to be
detrimental. Longer follow-up with additional somatic growth is
required to see whether this finding remains true.
The challenge that the authors have is convincing us whether
artificial chordae were, in fact, necessary for successful repair in
many of their patients because 100% of patients also had concom-
itant annuloplasty.
You noted that half of your patients, 51%, had anterior leaflet
prolapse with intact chordae, the other half having unsupported
segments caused by torn or absent chordae. Given the fact that it
has been shown that proper annuloplasty alone can effectively
reduce or eliminate MR as a result of isolated leaflet prolapse with
intact chordae, it is difficult to know how essential it was to place
chordae in the group of patients who had no unsupported seg-
ments.
I agree with the authors, and it has been our practice to use
artificial chordae to treat an unsupported segment of the anterior
leaflet for successful valve repair.
My questions are as follows. First, only 13%, or 5 patients, had
severe MR preoperatively. Could you comment on the late results
of these particular patients?
Second, what was the outcome of the group of patients with
unsupported segments of the anterior leaflet?
Third, do you use leaflet resection or artificial chordae for the
management of a flail posterior leaflet?
Dr Minami. To answer the first question, there was no link to
MR in 4 patients at the latest follow-up; however, a 5-month-old
boy required redo MV plasty 2 years after the initial operation
because of new anterior leaflet prolapse. And the second question
is about prolapse of anterior mitral leaflets?
Dr Dearani. As to the 50% of patients who had an unsupported
segment of the anterior leaflet, the ones who truly needed the
artificial chordae, how did they do compared with the patients who
had an intact chordae?
The difficulty that I have, when the cords are intact, is that it is
hard to know whether it is important to place artificial cords if you
342 The Journal of Thoracic and Cardiovascular Surgery ● Febrdo an annuloplasty anyway. The patients who truly need the cords
are the ones who have absent chordae or torn chordae. How did
those patients do in late follow-up? Because if there is a problem
with the artificial cord, then they will be more likely to have
recurrent regurgitation. Did those patients do as well as the ones
who had cords that were not disrupted? Was there a difference
between the 2 groups? Does that make sense?
Dr Minami. In 19 patients with torn or absent chordae, less
than trivial MR was observed in 16 (84%) patients, mild MR in 1
patient, and moderate MR in 2 patients at the latest follow-up. Two
patients with moderate MR required reoperations 17 days and 2
years after repair. In another group with elongated chordae, less
than trivial MR was observed in 17 (85%) patients, mild MR in 2
patients, and moderate MR in 1 patient, who required reoperation
5 years after repair. There was no difference between the 2 groups
in late outcome.
Dr Dearani. When you have a ruptured cord to the posterior
leaflet, do you put an artificial cord, or do you do a little resection
of the leaflet?
Dr Minami. We have never introduced artificial chordae for
posterior leaflet prolapse. We could correct them by using leaflet
resection and mitral annuloplasty.
Dr Alain Carpentier (Paris, France). I do not want to embar-
rass you, but I think this is a very important article to be discussed.
I congratulate you for demonstrating that contrary to what we
could expect, you have not seen any restricted leaflet motion after
the use of artificial cords.
It does not mean that this is the ideal solution because the fact
that you overnarrow the orifice with a Reed annuloplasty does not
provide a normal physiology of the MV, as pointed out by the first
discussant.
My only question is as follows: Why do you use artificial cords,
which cannot increase their length as the heart grows, rather than
native cords? There are always enough native cords that can be
transposed from one leaflet to the other or from one location (basal
or intermediate chords) to another location (marginal). It is a very
reliable technique.
I have operated on several hundred children, including 120 or
130 with congenital malformations, without finding it necessary to
use artificial cords. Why do you think it is necessary to follow the
current tendency of using artificial rather than natural materials?
Dr Minami. Our ideal operation for MR is perfect repair only
with natural material. We used to try chordal transfer and wedge
resection, as you have described in the literature, until 1995, and
therefore before the first period. But the operative results were not
satisfactory, with many reoperations and deaths. We could not
anticipate operative outcome after repair, and therefore we
changed to use of artificial chordae.
uary 2005
